Ibrutinib-Induced Lymphocytosis: Cytological Features

Acta Haematol. 2017;137(1):55-57. doi: 10.1159/000452437. Epub 2016 Dec 14.
No abstract available

MeSH terms

  • Adenine / analogs & derivatives
  • Agammaglobulinaemia Tyrosine Kinase
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Chromosome Aberrations*
  • Female
  • Gene Expression
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / enzymology
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Lymphocyte Count
  • Lymphocytosis / chemically induced
  • Lymphocytosis / diagnosis*
  • Lymphocytosis / pathology
  • Male
  • Middle Aged
  • Piperidines
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Pyrazoles / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • Adenine